MacLean Michael F

CIK 00013837316 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001383731

Recent Transactions

50 trades

Award
Camp4 Therapeutics Corp$CAMP
Stock Option (Right to Buy)
2026-04-01+56,000→ 56,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−50,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−106,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−60,125→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−133,977→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−148,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−131,250→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−92,000→ 0 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−1,807→ 62,025 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−2,735→ 59,290 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-07$72.23/sh−1,974→ 63,832 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.73/sh−30,914→ 65,806 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−42,200→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−136,139→ 0 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-06-05+42,200→ 42,200 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-20$31.06/sh−7,935→ 96,720 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−1,665→ 104,655 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−1,622→ 106,320 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-06+25,000→ 107,942 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-01-06+50,000→ 50,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-12-18$32.66/sh−11,151→ 82,942 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-11-06$6.57/sh+13,875→ 107,968 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-11-06$45.33/sh−13,875→ 94,093 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-11-06$8.82/sh+65,182→ 159,275 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-11-06−65,182→ 0 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-11-06−13,875→ 60,125 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-11-06$45.33/sh−65,182→ 94,093 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-11-06$46.22/sh−27,262→ 94,093 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-23$44.00/sh−11,510→ 96,355 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+25,000→ 107,865 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-09-19+25,000→ 121,355 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-06-26+136,139→ 136,139 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-18$39.13/sh−11,228→ 57,865 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+25,000→ 69,093 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-17+25,000→ 82,865 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-06-12−104,245→ 65,182 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-12$35.72/sh−104,245→ 44,093 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-06-12$8.82/sh+104,245→ 148,338 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-05-14−75,000→ 169,427 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-05-14$28.28/sh−75,000→ 44,093 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-05-14$8.82/sh+75,000→ 119,093 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-03-13−40,000→ 244,427 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-03-13$24.52/sh−40,000→ 44,093 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-03-13$8.82/sh+40,000→ 84,093 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-01-22$10.13/sh−1,616→ 16,884 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2024-01-20+106,000→ 106,000 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2024-01-20+22,500→ 27,209 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2023-09-11+74,000→ 74,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-06-15+26,642→ 26,642 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-02-14+7,000→ 7,000 total

Companies

Recent Filings

Address

C/O RESEARCH ALLIANCE CORPORATION III 600 FIFTH AVENUE, 23RD FLOOR

NEW YORK, NY, 10020

View on SEC.gov